Is KORU Medical Systems, Inc. (KRMD) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.9% / 30% | 4.5% / 30% | 2.8% / 30% | 1.32% / 5% | ✓ HALAL |
| DJIM | 1.9% / 33% | 4.5% / 33% | 2.8% / 33% | 1.32% / 5% | ✓ HALAL |
| MSCI | 14.7% / 33% | 35.2% / 33% | 22.0% / 33% | 1.32% / 5% | ✗ NOT HALAL |
| S&P | 1.9% / 33% | 4.5% / 33% | 2.8% / 33% | 1.32% / 5% | ✓ HALAL |
| FTSE | 14.7% / 33% | 35.2% / 33% | 22.0% / 50% | 1.32% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 62.3% | |
| Operating Margin | -5.0% | |
| Net Margin | -6.4% | |
| Return on Equity (ROE) | -15.6% | |
| Return on Assets (ROA) | -6.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $462,405 |
| Free Cash Flow | -$494,085 |
| Total Debt | $3M |
| Debt-to-Equity | 20.5 |
| Current Ratio | 2.4 |
| Total Assets | $28M |
Price & Trading
| Last Close | $4.36 |
| 50-Day MA | $4.85 |
| 200-Day MA | $4.45 |
| Avg Volume | 196K |
| Beta | 0.5 |
|
52-Week Range
$1.86
| |
About KORU Medical Systems, Inc. (KRMD)
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Purification Calculator
As a halal stock with 1.32% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is KORU Medical Systems, Inc. (KRMD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), KORU Medical Systems, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is KORU Medical Systems, Inc.'s debt ratio?
KORU Medical Systems, Inc.'s debt ratio is 1.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 14.7%.
Does KORU Medical Systems, Inc. require dividend purification?
Yes, KORU Medical Systems, Inc. has an impermissible income ratio of 1.32%, which means 1.32% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are KORU Medical Systems, Inc.'s key financial metrics?
KORU Medical Systems, Inc. has a market capitalization of $196M, and revenue of $41M. The company maintains a gross margin of 62.3% and a net margin of -6.4%. Return on equity stands at -15.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.